Journal
MOLECULAR NEUROBIOLOGY
Volume 48, Issue 3, Pages 941-951Publisher
HUMANA PRESS INC
DOI: 10.1007/s12035-013-8479-6
Keywords
Prdx6; A beta; iNOS; Nrf2
Categories
Funding
- National Research Foundation of Korea (NRF)
- Korean Government [MRC 2011-0028213]
- Korean Health Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [A101836]
- Priority Research Centres Program through the NRF
- Ministry of Education, Science and Technology [2012-0031403]
Ask authors/readers for more resources
The amyloid beta (A beta) peptide in the brains of patients with Alzheimer's disease (AD) is cytotoxic to neurons and has a central role in the pathogenesis of the disease. Peroxiredoxin 6 (Prdx6) is an antioxidant protein and could act as a cytoprotective protein. However, the role of Prdx6 in neurodegenerative disease has not been studied. Thus, the roles and action mechanisms in the development of AD were examined. A beta(1-42)-induced memory impairment in Prdx6 transgenic mice was worse than C57BL/6 mice, and the expression of amyloid precursor protein cleavage, C99, beta-site APP-cleaving enzyme 1, inducible nitric oxide synthase, and cyclooxygenase-2 was greatly increased. In addition, the astrocytes and microglia cells of A beta-infused Prdx6 transgenic mice were more activated, and A beta also significantly increased lipid peroxidation and protein carbonyl levels, but decreased glutathione levels. Furthermore, we found that translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) to the nucleus was increased in A beta-infused Prdx6 transgenic mice. These results suggest that the overexpression of Prdx6 could accelerate the development of AD through increased amyloidogenesis through independent PLA2 activation and Nrf2 transcription.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available